AAAAAA

   
Results: 1-10 |
Results: 10
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry
Authors: Vose, JM Zhang, MJ Rowlings, PA Lazarus, HM Bolwell, BJ Freytes, CO Pavlovsky, S Keating, A Yanes, B van Besien, K Armitage, JO Horowitz, MM
Citation: Jm. Vose et al., Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry, J CL ONCOL, 19(2), 2001, pp. 406-413
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
Authors: Lazarus, HM Loberiza, FR Zhang, MJ Armitage, JO Ballen, KK Bashey, A Bolwell, BJ Burns, LJ Freytes, CO Galeg, RP Gibson, J Herzig, RH LeMaistre, CF Marks, D Mason, J Miller, AM Milone, GA Pavlovsky, S Reece, DE Rizzo, JD van Besien, K Vose, JM Horowitz, MM
Citation: Hm. Lazarus et al., Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR), BONE MAR TR, 27(4), 2001, pp. 387-396
Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphomapatients: A randomized prospective study
Authors: Gazitt, Y Callander, N Freytes, CO Shaughnessy, P Liu, Q Tsai, TW Devore, P
Citation: Y. Gazitt et al., Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphomapatients: A randomized prospective study, J HEMATH ST, 9(5), 2000, pp. 737-748
Indications and complications of intravenous devices for chemotherapy
Authors: Freytes, CO
Citation: Co. Freytes, Indications and complications of intravenous devices for chemotherapy, CURR OPIN O, 12(4), 2000, pp. 303-307
Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation
Authors: Akasheh, MS Freytes, CO Vesole, DH
Citation: Ms. Akasheh et al., Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation, BONE MAR TR, 26(10), 2000, pp. 1107-1109
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group
Authors: Wolff, SN Fay, J Stevens, D Herzig, RH Pohlman, B Bolwell, B Lynch, J Ericson, S Freytes, CO LeMaistre, F Collins, R Pineiro, L Greer, J Stein, R Goodman, SA Dummer, S
Citation: Sn. Wolff et al., Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group, BONE MAR TR, 25(8), 2000, pp. 853-859
Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization
Authors: Gazitt, Y Freytes, CO Callander, N Tsai, TW Alsina, M Anderson, J Holle, L Cruz, J Devoer, P McGrath, M West, G Alvarez, R Montgomery, W
Citation: Y. Gazitt et al., Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization, J HEMATOTH, 8(2), 1999, pp. 173-183
Vascular access investigation comes of age
Authors: Freytes, CO
Citation: Co. Freytes, Vascular access investigation comes of age, SUPP CARE C, 7(6), 1999, pp. 373-374
Autotransplants in men with breast cancer
Authors: McCarthy, PL Hurd, DD Rowlings, PA Crump, M Gale, RP Lazarus, HM Vaughan, WP Weinberger, BB Wiemann, MC Freytes, CO Cirenza, E Antman, KH
Citation: Pl. Mccarthy et al., Autotransplants in men with breast cancer, BONE MAR TR, 24(4), 1999, pp. 365-368
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer
Authors: Rowlings, PA Williams, SF Antman, KH Fields, KK Fay, JW Reed, E Pelz, CJ Klein, JP Sobocinski, KA Kennedy, MJ Freytes, CO McCarthy, PL Herzig, RH Stadtmauer, EA Lazarus, HM Pecora, AL Bitran, JD Wolff, SN Gale, RP Armitage, JO Vaughan, WP Spitzer, G Horowitz, MM
Citation: Pa. Rowlings et al., Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer, J AM MED A, 282(14), 1999, pp. 1335-1343
Risultati: 1-10 |